StocksMedium•19 October 2026•
1 min read
Eli Lilly Signs $1.1 Billion Drug Delivery Deal with Metis TechBio
Key Facts
1Metis TechBio has entered into a collaboration agreement with Eli Lilly for drug delivery technology worth up to $1.1 billion.
Metis TechBio has entered into a collaboration agreement with Eli Lilly for drug delivery technology worth up to $1.1 billion. Reuters reported that the partnership aims to leverage Metis TechBio's specialized technology to enhance the delivery mechanisms of Eli Lilly's pharmaceutical pipeline.
LLY closed at $1257.03 on October 16, 2026, after reaching a day high of $1274.56 and a low of $1251.25. This R&D investment represents a strategic move to strengthen the company's technical capabilities within the biopharmaceutical sector.